Salarius Pharmaceuticals/ US79400X3052 /
| 2024-04-22 6:25:05 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.50USD | - | 100 Turnover: 49.90 |
-Bid Size: - | -Ask Size: - | 0.50 | 0.50 |
GlobeNewswire
03-22
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Bu...
GlobeNewswire
02-22
Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clini...
GlobeNewswire
01-16
Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders
GlobeNewswire
01-03
Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Comb...
GlobeNewswire
2023-11-07
Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
GlobeNewswire
2022-03-10
Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2021 Financia...
GlobeNewswire
2022-03-03
Salarius Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results and Highlight...
GlobeNewswire
2022-02-17
Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational 2022...
GlobeNewswire
2022-02-08
Salarius Pharmaceuticals to Participate in the 2022 BIO CEO & Investor Conference
GlobeNewswire
2022-02-03
Salarius Pharmaceuticals Appoints Daniela Santiesteban, Ph.D., to Director of Targeted Protein Degra...
GlobeNewswire
2022-01-13
Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein...
GlobeNewswire
2022-01-06
Salarius Pharmaceuticals to Present at Virtual H.C. Wainwright BioConnect, Participate in Virtual Bi...
GlobeNewswire
2021-12-29
Salarius Pharmaceuticals Achieves Dosing Milestone in Ongoing Phase 1/2 Sarcoma Trial
GlobeNewswire
2021-12-15
Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum
GlobeNewswire
2021-11-29
Salarius Pharmaceuticals to Participate in Annual Benchmark Company Discovery One-on-One Conference
GlobeNewswire
2021-11-18
The Benchmark Company Announces Its Upcoming 10th Annual One-on-One Discovery Conference
GlobeNewswire
2021-11-04
Salarius Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Company ...
GlobeNewswire
2021-10-26
Salarius Pharmaceuticals to Report Third Quarter 2021 Financial Results and Highlight Recent Company...
GlobeNewswire
2021-10-07
Salarius Pharmaceuticals and Nationwide Children’s Hospital Disclose Research Findings from Presenta...
GlobeNewswire
2021-09-30
Salarius Pharmaceuticals and Nationwide Children’s Hospital Announce Poster Presentation at the 2021...
GlobeNewswire
2021-09-28
Salarius Pharmaceuticals Receives $2.7 Million in Payment from the Cancer Prevention and Research In...
GlobeNewswire
2021-09-27
Salarius Pharmaceuticals to Present at the Virtual Benzinga Healthcare Small Cap Conference
GlobeNewswire
2021-09-22
Salarius Pharmaceuticals and Fox Chase Cancer Center Launch Research Partnership
GlobeNewswire
2021-09-20
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
